Diagnosis and treatment of substance use disorders in patients with HIV infection

International Review of Psychiatry

Volumn 8, Issue 2-3, 1996, Pages 245-252

  Batki, Steven L ^a   Ferrando, Stephen J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DEPENDENCE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENTAL DISEASE; NEUROPSYCHIATRY; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SUBSTANCE ABUSE; SYMPTOM;

EID: 0029904494     PISSN: 09540261     EISSN: None     Source Type: Journal    
DOI: 10.3109/09540269609046308     Document Type: Review

References (55)

1. AMERICAN PSYCHIATRIC ASSOCIATION (1995) Work group on substance use disorders. Practice guidelines for the treatment of patients with substance use disorders: alcohol, cocaine, opioids, American Journal of Psychiatry, 152(11 Suppl.) pp.1-59.
2. AMERICAN PSYCHIATRIC ASSOCIATION (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (Washington, DC, American Psychiatric Press).
3. AYUSO, J. L. (1994) Use of psychotropic drugs in patients with HIV infection, Drugs, 47, pp. 599-610.
4. BAKER, A., HEATHER, N., WODAK, A., DIXON, J. & HOLT, P. (1993) Evaluation of a cognitive-behavioral intervention for HIV prevention among injecting drug users, AIDS, 7, pp. 247-256.
5. BATKI, S. L. (1990a) Drug abuse, psychiatric disorders, and AIDS: dual and triple diagnosis, Western Journal of Medicine, 152, pp. 547-552.
6. BATKI, S. L. (1990b) Buspirone in drug users with AIDS or AIDS-Related Complex, Journal of Clinical Psychopharmacology, 10 (3 Suppl), pp. 111S-115S.
7. BATKI, S. L., SORENSEN, J. L., GIBSON, D. R. & MAUDE-GRIFFIN, P. (1990) HIV-infected IV drug users in methadone treatment: outcome and psychological correlates - a preliminary report, in: L. S. HARRIS (Ed) Problems of drug dependence 1989: proceedings of the 51st Annual Scientific Meeting of the Committee on the Problems of Drug Dependence: NIDA Research Monograph Series, 95, pp. 405-406. DHHS Pub. No. (ADM) 90-1663 (Washington DC, US Government Printing Office).
8. BATKI, S. L., MANFREDI, L. B., JACOB, P. III, DELUCCHI, K., MURPHY, J., WASHBURN, A., GOLDBERGER, L. & JONES, R. T. (1993) Double-blind fluoxetine treatment of cocaine dependence in methadone maintenance treatment (MMT) patients-Interim analysis, in: L. S. HARRIS (Ed) Problems of drug dependence 1992: proceedings of the 54th Annual Scientific Meeting, the College on the Problems of Drug Dependence. NIDA Research Monograph Series, 132, p. 102 (National Institute on Drug Abuse, NIH Public. No. 93-3505).
9. BATKI, S. L., FERRANDO, S. J., MANFREDI, L. B., LONDON, J., PATTILLO, J. & DELUCCHI, K. (1996) Psychiatric disorders, drug use, and medical status in 84 injection drug users with HIV disease, American Journal on Addictions, 5, pp. 249-258.
10. BROERS, B., MORABIA, A. & HIRSCHEL, B. (1994) A cohort study of drug users' compliance with zidovudine treatment, Archives of Internal Medicine, 154, pp. 1121-1127.
11. CARBALLO-DIEGUEZ, A. J., GOETZ, R., EL SADR, W., SORELL, S. & GORMAN, J. (1994) The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users, American Journal of Drug and Alcohol Abuse, 20, pp. 317-329.
12. CASADONTE, P. P., DES JARLAIS, D. C., FRIEDMAN, S. R. & ROTROSEN, J. P. (1990) Psychological and behavioral impact among intravenous drug users learning HIV test results, International Journal of the Addictions, 25, pp. 409-26.
13. CENTER FOR SUBSTANCE ABUSE TREATMENT (1995) Treatment for HIV-infected alcohol and other drug users. DHHS Publication No. (SMA) 95-3038 (Washington DC, US Government Printing Office).
14. CENTERS FOR DISEASE CONTROL AND PREVENTION (1995a) HIV/AIDS Surveillance Report. Atlanta: US Department of Health and Human Services, Public Health Service, 7, pp. 1-8.
15. CENTERS FOR DISEASE CONTROL AND PREVENTION (1995b) First 500,000 AIDS cases - United States, 1995, Morbidity and Mortality Weekly Report, 46, pp. 849-853.
16. CENTERS FOR DISEASE CONTROL AND PREVENTION (1996) Continued sexual risk behavior among HIV-seropositive, drug-using men - Atlanta; Washington, DC; and San Juan, Puerto Rico, Morbidity and Mortality Weekly Report, 45, pp. 151-152.
17. CHAISSON, R. E., KERULY, J. C. & MOORE, R. D. (1995) Race, sex, drug use, and progression of human immunodeficiency virus disease, New England Journal of Medicine, 333, pp. 751-756.
18. COLE, J. O., ORZACK, M. H., BEAKE, B., BIRD, M. & BAR-TAL, Y. (1982) Assessment of the abuse liability of buspirone in recreational sedative users, Journal of Clinical Psychiatry, 43, pp. 69-75.
19. DAVIS, R. F., METZGER, D. S., MEYERS, K., MCLELLAN, A. T., MULVANEY, F. D., NAVALINE, H. A. & WOODY, G. E. (1995) Long-term changes in psychological symptomatology associated with HIV serostatus among male injecting drug users, AIDS, 9, pp. 73-9.
20. DIAZ, T., CHU, S. Y., BYERS, R. H., HERSH, B. S., CONTI, L., RIETMAJER, C. A., MOKOTOFF, E., FANN, A. S., BOYD, D., IGLESIAS, L., CHECKO, P. J., FREDERICK, M., HERMANN, P., HERR, M. & SAMUEL, M. C. (1994) The types of drugs used by HIV-infected injection drug users in a multistate surveillance project: Implications for prevention, American Journal of Public Health, 84, pp. 1971-1975.
21. EGAN, V. G., CRAWFORD, J. R., BRETTLE, R. P. & GOODWIN, G. M. (1990) The Edinburgh cohort of HIV-positive drug users: current intellectual function is impaired but not due to early AIDS dementia complex, AIDS, 4, pp. 651-656.
22. ESKILD, A., MAGNUS, P., SOHLBERG, C., KTTTELSEN, P., OLVING, J. H., TEIGE, B. & SKULLERUD, K. (1994) Slow progression to AIDS in intravenous drug users infected with HIV in Norway, Journal of Epidemiology and Community Health, 48, pp, 383-387.
23. FRIEDMAN, J. B., O'DOWD, M. A., MCKEGNEY, P. F., KAPLAN, I. J., BERNSTEIN, G., BIDERMAN, D. J. & GOMEZ, M. F. (1996) Managing diazepam abuse in an AIDS-related psychiatric clinic with a high percentage of substance abusers, Psychosomatics, 37, pp. 43-47.
24. GOOSBY, E., BATKI, S. L., LONDON, J. A., FERRANDO, S. J., RYAN, C., HARTWIG, R. & ABBOT, C. (1992) Medical care of HIV disease in methadone maintenance treatment, in: L. S. HARRIS (Ed) Problems of drug dependence 1991: proceedings of the 53rd Annual Scientific Meeting, The Committee on the Problems of Drug Dependence. NIDA Research Monograph Series, 119, p. 431, DHHS Pub. No. (ADM) 92-1888 (Washington DC, US Government Printing Office).
25. HU, D. J., BYERS, R. JR., FLEMING, P. L. & WARD, J. W. (1995) Characteristics of persons with late AIDS diagnosis in the United States, American Journal of Preventive Medicine, 11, pp. 114-119.
26. JAMES, M. E., RUBIN, C. P. & WILLIS, S. E. (1991) Drug abuse and psychiatric finding in HIV-seropositive pregnant patients, General Hospital Psychiatry, 13, pp. 4-8.
27. KANTER, J. (1989) Clinical case management: definition, principles, components, Hospital and Community Psychiatry, 30, pp. 361-368.
28. KHANTZIAN, E. J. & TREECE, C. (1985) DSM III psychiatric diagnosis of narcotic addicts, Archives of General Psychiatry, 42, pp. 1067-1071.
29. LIPSTIZ, J. D., WILLIAMS, J. B., RABKIN, J. G., REMIEN, R. H., BRADBURY, M., EL SADR, W., GOETZ, R., SORRELL, S. & GORMAN, J. M. (1994) Psychopathology in male and female intravenous drug users with and without HIV infection, American Journal of Psychiatry, 151, pp. 1662-1668.
30. LYKETSOS, C. G., HANSON, A., FISHMAN, M., MCHUGH, P. R. & TREISMAN, G. J. (1994) Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presence, International Journal of Psychiatry in Medicine, 24, pp. 103-113.
31. LYKETSOS, C. G. & FEDERMAN, E. B. (1995) Psychiatric disorders and HIV infection: impact on one another, Epidemiologic Reviews, 17, pp. 152-164.
32. MAUSKOPF, J., TURNER, B. J., MARKSON, L. E., HOUCHENS, R. L., FANNING, T. R. & MCKEE, L. (1994) Patterns of ambulatory care for AIDS patients, and association with emergency room use, Health Services Research, 29, pp. 489-510.
33. MCDANIEL, J. S., FOWLIE, E., SUMMERVILLE, M. B., FARBER, E. W. & COHEN-COLE, S. A. (1995) An assessment of rates of psychiatric morbidity and functioning in HIV disease, General Hospital Psychiatry, 17, pp. 346-352.
34. MCKEGNEY, F. P., O'DOWD, M. A., FEINER, C., SELWYN, P., DRUCKER, E. & FRIEDLAND, G. (1990) A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients, AIDS, 4, pp. 565-569.
35. MCLELLAN, A. T., LUBORSKY, L., WOODY, G. E., O'BRIEN, C. P. & DRULEY, K. (1983) Predicting response to drug and alcohol treatments: role of psychiatric severity, Archives of General Psychiatry, 40, pp. 620-625.
36. METZGER, D. S., WOODY, G. E., MCLELLAN, A. T., O'BRIEN, C. P., DRULEY, P., NAVALINE, H., DEPHILIPPIS, D., STOLLEY, P. & ABRUTYN, E. (1993) Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up, Journal of Acquired Immune Deficiency Syndromes, 6, pp. 1049-1056.
37. MIRIN, S. M., WEISS, R. D. & MICHAEL, J. (1988) Psychopathology in substance abusers: diagnosis and treatment, American Journal of Drug and Alcohol Abuse, 14, pp. 139-157.
38. MOHR, V., FLEISHMAN, J. A., DRESSER, M. & PIETTE, J. (1992) Variation in health service use among HIV-infected patients, Medical Care, 30, pp. 17-29.
39. PAKESCH, G., LOIMER, N., GRUNBERGER, J., PFERSMANN, D., LINZMAYER, L. & MAYERHOFER, S. (1992) Neuropsychological findings and psychiatric symptoms in HIV-1 infected and noninfected drug users, Psychiatry Research, 41, pp. 163-177.
40. PERRY, S., JACOBSBERG, L., CARD, C. A., ASHMAN, T., FRANCES, A. & FISHMAN, B. (1993) Severity of psychiatric symptoms after HIV testing, American Journal of Psychiatry, 150, pp. 775-779.
41. POHL, M. I. (1991) Residential treatment for chemically dependent clients with HIV, Journal of Chemical Dependency Treatment, 4, pp. 131-140.
42. SELWYN, P. A., BUDNER, N. S., WASSERMAN, W. C. & ARNO, P. S. (1993) Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program, Public Health Reports, 108, pp. 492-500.
43. SELWYN, P. A., FEINGOLD, A., IEZZA, A., SATYADEO, M., COLEY, J., TORRES, R. & SHAW, J. F. M. (1989) Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program, Annals of Internal Medicine, 111, pp. 761-763.
44. SENAY, E. (1992) Diagnostic interview and mental status examination, in J. H. LOWINSON, P. RUIZ, R. B. MILLMAN & J. LANGROD (Eds) Substance Abuse: a comprehensive textbook, 2nd ed. pp. 416-424 (Baltimore, Williams and Wilkins).
45. SERPELLONI, G., CARRIERI, M. P., REZZA, G., MORGANTI, S., GOMMA, M. & BINKIN, N. (1994) Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study, AIDS Care, 6, pp. 215-20.
46. SEWELL, D. D., JESTE, D. V., ATKINSON, J. H., HEATON, R. K., HESSELINK, J. R., WILEY, C., THAL, L., CHANDLER, J. L. & GRANT, I. (1994) HIV-associated psychosis: a study of 20 cases. San Diego HIV Neurobehavioral Research Center Group, American Journal of Psychiatry, 151, pp. 237-242.
47. SOLOMON, L., FRANK, R., VLAHOY, D. & ASTEMBORSKI, J. (1991) Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus, American Journal of Public Health, 81, pp. 1285-1289.
48. SORENSEN, J. L. & BATKI, S. L. (1992a) Methadone maintenance as a setting for treating drug abusers with HIV infection, Psychology of Addictive Behaviors, 6, pp. 126-130.
49. SORENSEN, J. L. & BATKI, S. L. (1992b) Management of the psychosocial sequelae of HIV infection among drug abusers, in: J. H. LOWINSON, P. RUIZ, R. B. MILLMAN & J. LANGROD (Eds) Substance abuse: a comprehensive textbook, 2nd ed., pp. 788-792 (Baltimore, Williams and Wilkins).
50. UMBRICHT-SCHNEITER, A., GINN, D. H., PABST, K. M. & BIGELOW, G. E. (1994) Providing medical care to methadone clinic patients, referral versus on-site care, American Journal of Public Health, 84, pp. 207-210.
51. VAN HAASTRECHT, M. J., MIENTJES, G. H., VAN DEN HOEK, A. J. & COUTINHO, R. A. (1994) Death from suicide and overdose among drug injectors after disclosure of first HIV test result, AIDS, 8, pp. 1721-1725.
52. VEREBEY, K. (1992) Diagnostic laboratory: screening for drug abuse, in J. H. LOWINSON, P. RUIZ, R. B. MILLMAN & J. LANGROD (Eds) Substance abuse: a comprehensive textbook, 2nd ed., pp. 425-436 (Baltimore, Williams and Wilkins).
53. WALL, T. L., SORENSEN, J. L., BATKI, S. L., DELUCCHI, K. L., LONDON, J. A. & CHESNEY, M. A. (1995) Adherence to zidovudine (AZT) among HIV-infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care, Drug and Alcohol Dependence, 37, pp. 261-269.
54. WEBER, R., LEDERGERBER, B., OPRAVIL, M., SIEGENTHALER, W. & LUTHY, R. (1990) Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone, British Medical Journal, 301, pp. 1362-1365.
55. WEDDINGTON, W. W., HAERTZEN, C. A., HESS, J. M. & BROWN, B. S. (1991) Psychological reactions and retention by cocaine addicts during treatment according to HIV-serostatus: a matched-control study, American Journal of Drug and Alcohol Abuse, 17, pp. 355-368.